Twin Cities Startup Week 2021 Twin Cities Startup Week 2021
Register to build your agenda.

Negotiating Collaboration Agreements with Large Companies: What to Expect

- CDT
Hopin 35

Ann Ladd
Fredrikson, Shareholder

Ann is a shareholder in Fredrikson's LIfe Science practice group, where she helps clients commercialize intellectual property and technology rights through a variety of transactions.  Her knowledge of privacy and cybersecurity allows her to help guide clients as they navigate rights to “big data,” annex artificial intelligence, compliance with state and federal laws, and evolving industry standards for contracting around compliance and risk sharing in these areas, which are increasingly important in IP transactions.

Rhona Schwaid
Medtronic, Strategic Legal Counsel

Rhona has over 18 years of experience advising businesses in the medical device industry. Rhona is skilled in Complex Business Development Transactions, M&A, Contracting, and Strategy. Rhona is known for providing practical legal advice with excellent service.

Jeffrey Steinle
Fredrikson & Byron, P.A., Attorney

Jeff is a corporate attorney who advises life science companies executing M&A, financing, joint venture, licensing and commercial transactions.  He serves as outside general counsel to life science companies and navigates highly regulated environments and negotiates effective strategic and commercial relationships to help clients develop, commercialize and sell their products. Jeff co-chairs Fredrikson & Byron's Life Sciences Group. He chairs the Board of Directors of the Minneapolis Heart Institute Foundation and serves on the Board of Pillsbury United Communities.

Aleida Conners
Medtronic, Senior Counsel

Aleida is a Senior Counsel at Medtronic, assisting with the company’s strategic partnerships, mergers, acquisitions, divestitures, and equity investments. Prior to that, she worked in private practice as a corporate and mergers and acquisitions attorney.


This presentation will discuss five different types of collaborative arrangements commonly used by large strategic life sciences companies to collaborate with start-up companies, either as part of strategic transactions, venture capital investments or joint ventures. The discussion will address issues and strategies for product development, patent and technology licenses, data sharing arrangements, distribution agreements and joint steering committee agreements.